SEC Form 4 · accession 0001103780-15-000017

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CEO · Director · 10% Owner

Period of report

Jan 20, 2010

Accepted (ET)

Apr 15, 2015 · 5:42 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001348362

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Shares	Apr 13, 2015	P	25,000	$0.10	A	3,273,794	D
Common Shares	Apr 13, 2015	P	10,000	$0.103	A	3,283,794	D
Common Shares	Apr 14, 2015	P	35,000	$0.102	A	3,318,794	D
Common Shares	Apr 15, 2015	P	45,000	$0.103	A	3,363,794	D
Common Shares^F1	Apr 15, 2015	P	50,000	$0.13	A	3,413,794	D
Common Shares	holding	—	—		—	4,318,958	I	Private Holding Company
Common Shares	holding	—	—		—	3,248,794	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options	$0.11	holding	—	—	—	Dec 23, 2014	Dec 23, 2019	Common Shares	500,000	500,000	D
Stock Options	$0.35	holding	—	—	—	Jul 11, 2011	Jul 11, 2016	Common Shares	200,000	700,000	D
Stock Options	$0.10	holding	—	—	—	Jun 18, 2013	Jun 18, 2018	Common Shares	225,000	925,000	D
Warrants	$0.25	holding	—	—	—	Mar 21, 2014	Sep 21, 2015	Common Shares	100,067	1,025,067	D